期刊名称 | Expert Opinion on Drug Safety EXPERT OPIN DRUG SAF |
---|---|
期刊ISSN | 1474-0338 |
期刊官方网站 | https://www.tandfonline.com/journals/ieds20 |
是否OA | No |
出版商 | Taylor and Francis Ltd. |
出版周期 | Bimonthly |
文章处理费 | 登录后查看 |
始发年份 | 2002 |
年文章数 | 155 |
影响因子 | 3.0(2023) scijournal影响因子 greensci影响因子 |
大类学科 | 小类学科 | Top | 综述 |
---|---|---|---|
医学3区 | PHARMACOLOGY & PHARMACY 药学3区 | 否 | 是 |
CiteScore排名 | CiteScore | SJR | SNIP | ||
---|---|---|---|---|---|
学科 | 排名 | 百分位 | 5.9 | 0.905 | 0.933 |
Medicine Pharmacology (medical) |
78/272 | 71% |
自引率 | 3.3% |
---|---|
H-index | 62 |
SCI收录状况 |
Science Citation Index Expanded |
官方审稿时间 | 登录后查看 |
网友分享审稿时间 | 数据统计中,敬请期待。 |
接受率 | 登录后查看 |
PubMed Central (PMC) | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1474-0338%5BISSN%5D |
期刊投稿网址 | https://mc.manuscriptcentral.com/eods |
---|---|
收稿范围 | Expert Opinion on Drug Safety [ISSN 1474-0338]; [e- ISSN 1744-764X] is a MEDLINE-indexed, international subscription-based journal publishing rigorously peer-reviewed review articles on all aspects of drug safety, as well as original papers on the clinical implications of drug treatment safety issues. Each article is structured to incorporate the author’s own expert opinion on the impact of the topic on research and clinical practice and the scope for future development. Expert Opinion on Drug Safety aims to address the needs of scientists, managers and decision-makers in the pharmaceutical industry, and others closely involved in monitoring drug safety. The journal welcomes: Reviews covering occurrence, management and prevention of drug-associated adverse events Reviews covering risk-benefit analyses of individual drugs and drug classes Reviews covering safety in 'at-risk' patient populations Reviews covering comparative tolerability studies Reviews covering pharmacovigilance and pharmacoepidemiological studies Drug safety evaluations reviewing the safety data on a specific drug Original research papers reporting the results of post-marketing surveillance and other safety studies looking at specific drugs, populations and outcomes Original research papers on methods for the detection and evaluation of drug-associated adverse events Please note that the journal does not publish case reports or animal studies. Letters to the Editor should discuss articles previously published in the journal. Comprehensive coverage in each review is complemented by the unique Expert Collection format and includes the following sections: Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results. Article Highlights – an executive summary of the author’s most critical points. Once your paper has been assessed for suitability by the Editorial Team, it will then be double-anonymous peer-reviewed by independent, expert referees. Reach an international clinical and medical audience alongside other key option leaders in your field by publishing with Expert Opinion on Drug Safety, part of the Expert Collection brand. |
收录体裁 | |
投稿指南 | https://www.tandfonline.com/action/authorSubmission?show=instructions&journalCode=ieds20 |
投稿模板 | |
参考文献格式 | |
编辑信息 |
|